drugset / Trial / NCT01319331
The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the drug Alpha-1 Antitrypsin (AAT, Aralast NP) will preserve beta-cell function and help slow the progression of type 1 diabetes.
Timeline
- Start
- 2010-10
- Primary completion
- 2015-10
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alpha 1-Antitrypsin | Protein / enzyme biologic | — | — |